Abstract:BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) accounts for >50% of heart failure cases and is associated with significant morbidity and health system burden. To date, there have been limited treatment options proven to improve outcomes in these patients, with sodium glucose co-transporter 2 (SGLT2) inhibitors the first class of drug to demonstrate significant clinical benefits, including reductions in heart failure hospitalisation. Obesity is associated with all forms of heart failure and has been linked with worse clinical outcomes. Numerous reviews support the benefits of weight loss in heart failure, more specifically in patients with heart failure with reduced ejection fraction. However, the evidence in HFpEF patients is less clear. With limited pharmacotherapy options and growing support for weight loss in patients with HFpEF, this systematic review and meta-analysis aims to examine the effects of lifestyle interventions on weight loss and other health outcomes in patients with HFpEF.METHODS: Web of Science, Embase, Scopus, and PubMed databases were searched to identify relevant studies up to February 2023. Included studies were randomised controlled trials (with a duration of four weeks or more) of lifestyle interventions conducted in adults with HFpEF that reported weight loss. Outcomes of interest were body weight, body mass index (BMI), blood pressure (systolic and diastolic), aerobic capacity (6-minute walk distance), New York Heart Association (NYHA) Functional Classification, self-reported health quality of life (Minnesota Living with Heart Failure Questionnaire; MLHFQ), and N-terminal pro B-Type Natriuretic Peptide (NT-proBNP) levels. Review Manager software was used to conduct random effect meta-analyses, forest plots were generated for each outcome, and between-study heterogeneity was estimated using the I<sup>2</sup> test statistic. Risk-of-bias assessment used the Cochrane risk-of-bias tool, and the certainty of the evidence was assessed using GRADE.RESULTS: From 2,282 records identified, six studies with a total of 375 participants, between three to six months in duration, were included in this systematic review and meta-analysis. Lifestyle interventions consisted of diet only, exercise only, combination of diet and exercise, and education and exercise. Over a mean follow-up of 4.5 months, pooled effects of the interventions were associated with a reduction in body weight of >5kg (weight mean difference (WMD): -5.30 kg; 95% CI: -8.72 to -1.87; p=0.002), and a reduction in resting systolic (WMD: -2.98 mmHg; 95% CI: -4.20 to -1.76; p<0.001) and diastolic blood pressure (WMD: -4.51 mmHg; 95% CI: -8.39 to -0.64; p=0.02) compared with those who received usual care. Interventions also improved 6-minute walk distance (WMD: 43.63 m; 95% CI: 22.28 to 64.97; p<0.001), NYHA class (WMD: -0.54; 95% CI: -0.75 to -0.33; p<0.001), and MLHFQ score (WMD: -17.77; 95% CL: -19.00 to -16.53; p<0.001).CONCLUSION: In patients with HFpEF, lifestyle intervention was associated with a significant reduction in body weight and had favourable effects on blood pressure, aerobic capacity, NYHA class, and health-related quality of life. Further research is needed in this population to examine the feasibility and durability of weight loss interventions and to examine the potential impact on hard clinical endpoints.

Effect of weight loss intervention on the outcomes in obese subjects with endothelial dysfunction

RELATIONSHIP OF VEIGHT REDUCTION WTTH ENDOTHELIUM-DEPENDENT DILATATION AND INSULIN RESISTANCE IN OBESE PEOPLE

Effect of Lifeway bar meal replacement on integrated health management in patients with overweight and obesity

Effect of Weight Reduction on Endothelial Function and Insulin Resistance in Obese Subjects

Effect of Meal Replacements on Body Weight Control and Blood Glucose and Lipid Profile

A preliminary study of relationship between endothelial dysfunction and insulin resistance in obese subjects

Seven-year Follow-Up Study of Relationship Between Endothelial Function and Risk Factors of Cardiovascular Diseases in Obese Subjects

A seven-year follow-up study of the relationship of endothelial function with insulin resistance and obese

Effect of lifestyle intervention on indexes of patients with dyslipidemia: a meta-analysis

Effects of Weight Reduction on Risk Factors of Cardiovascular Disease in Persons with Obesity and Overweight

The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Effect of lifestyle interventions on cardiovascular risk factors in overweight/obese individuals

Study of insulin resistance and insulin secretion function in overweight and obese subjects with endothelial dysfunction

Effects of a 12-Month Moderate Weight Loss Intervention on Insulin Sensitivity and Inflammation Status in Nondiabetic Overweight and Obese Subjects

Effects Of Low-Fat Compared With High-Fat Diet On Cardiometabolic Indicators In People With Overweight And Obesity Without Overt Metabolic Disturbance: A Systematic Review And Meta-Analysis Of Randomised Controlled Trials

Effect of Abdominal Obesity on Insulin Sensitivity and Its Community - Based Intervation

Effects of Low-Fat Compared with High-Fat Diet on Cardiometabolic Indicators in People with Overweight and Obesity Without Overt Metabolic Disturbance: a Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Impact of surgical and non-surgical weight loss on echocardiographic and strain parameters in Asian patients

The Effects of Weight Reduction on Resistin and Cardiovascular Risk Factors in Obese Persons

A Follow-up Study of the Relationship Between Endothelial Function and Insulin Resistance, Metabolic Syndrome in Obese Subjects

Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial